Status
Conditions
Treatments
About
To investigate the oncological outcome of lateral lymph node dissection in low rectal cancer based on MRI
Full description
Our study design is a multicenter, prospective, registry study.
We would enroll 268 patients with lower rectal cancer whose preoperative MRI showed laterally lymph node diameter ≥ 5mm.
The postoperative adjuvant chemoradiotherapy is determined by the pathological results. For patients of stage II and patients of stage III with unfavorable histologic features, six months of adjuvant chemotherapy of fluorouracil-based regimen with radiotherapy of 45.0 ~ 50.5 Gy are recommended.
The postoperative examination should be performed every three months in the first two years and every six months in the following three years.
Our study is expected to last five years, of which two years for recruiting patients, three years for follow-up.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
(9) R0 resection cannot complete (10) ASA grade ≥ IV
268 participants in 1 patient group
Loading...
Central trial contact
Qian Liu, M.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal